Rengasamy Balakrishnan
Overview
Explore the profile of Rengasamy Balakrishnan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
226
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ji Y, Yu Y, Rahman M, Balakrishnan R, Kim J, Kim J, et al.
Neurochem Int
. 2025 Feb;
185:105946.
PMID: 39971241
Microglial-mediated neuroinflammation significantly impacts cognitive impairment, and modulating neuroinflammatory responses has emerged as a promising target for treatment. However, the specific role of microglial-mediated neuroinflammation in cognitive impairment associated with...
2.
3.
Balakrishnan R, Kang S, Lee J, Rho Y, Kim B, Choi D
Aging Dis
. 2024 Dec;
PMID: 39656490
The human body contains approximately 100 trillion microorganisms, predominantly within the gastrointestinal tract, collectively called the gut microbiota. Investigations have revealed the bidirectional communication between the gut microbiota and the...
4.
Balakrishnan R, Jannat K, Choi D
Redox Biol
. 2024 Mar;
71:103105.
PMID: 38471283
Cognitive dysfunction can occur both in normal aging and age-related neurological disorders, such as mild cognitive impairment and Alzheimer's disease (AD). These disorders have few treatment options due to side...
5.
Choi J, Jo S, Kim D, Paik I, Balakrishnan R
Redox Biol
. 2024 Feb;
71:103101.
PMID: 38408409
Physical activity has been considered an important non-medication intervention in preserving mnemonic processes during aging. However, how aerobic exercise promotes such benefits for human health remains unclear. In this study,...
6.
Jannat K, Balakrishnan R, Han J, Yu Y, Kim G, Choi D
Cells
. 2023 Nov;
12(22).
PMID: 37998387
The most common neurodegenerative diseases (NDDs), such as Alzheimer's disease (AD) and Parkinson's disease (PD), are the seventh leading cause of mortality and morbidity in developed countries. Clinical observations of...
7.
Balakrishnan R, Kim Y, Kim G, Kim W, Hong S, Kim C, et al.
Biomed Pharmacother
. 2023 Jul;
165:115106.
PMID: 37421783
Mild cognitive impairment is a typical symptom of early Alzheimer's disease (AD). Glehnia littoralis (G. littoralis), a medicinal halophyte plant commonly used to treat strokes, has been shown to possess...
8.
Balakrishnan R, Azam S, Kim I, Choi D
Aging Dis
. 2023 May;
14(3):750-777.
PMID: 37191428
Age-related neurological disorders (ANDs), including neurodegenerative diseases, are multifactorial disorders whose risk increases with age. The main pathological hallmarks of ANDs include behavioral changes, excessive oxidative stress, progressive functional declines,...
9.
Balakrishnan R, Park J, Cho D, Ahn J, Yoo D, Seol S, et al.
Antioxidants (Basel)
. 2023 Mar;
12(3).
PMID: 36978896
Cognitive decline and memory impairment induced by oxidative brain damage are the critical pathological hallmarks of Alzheimer's disease (AD). Based on the potential neuroprotective effects of AD-1 small molecule, we...
10.
Raguvaran K, Kalpana M, Manimegalai T, Kalaivani S, Devapriya P, Siddharthan N, et al.
Arch Microbiol
. 2022 Sep;
204(10):650.
PMID: 36173486
Mosquitoes are a vector for many dreadful diseases known for their public health concern. The continued use of synthetic insecticides against vector control has led to serious environmental impacts, human...